Literature DB >> 25661355

Role of the interaction between galectin-3 and cell adhesion molecules in cancer metastasis.

Ming Xin1, Xin-Wen Dong1, Xiu-Li Guo2.   

Abstract

Galectin-3, a unique chimera-type member of the β-galactoside-binding soluble lectin family, is present in both normal and cancer cells and plays a crucial role in the regulation of cell adhesion. It is involved both in accelerating detachment of cells from primary tumor sites and promoting cancer cell adhesion and survival to anoikis in the blood stream. Cell adhesion molecules (CAMs) are membrane receptors that mediate cell-cell and cell-matrix interactions, and are essential for transducing intracellular signals responsible for adhesion, migration, invasion, angiogenesis, and organ-specific metastasis. This review will discuss the recent advances in our understanding the biological functions, mechanism and therapeutic implication of the interaction between galectin-3 and CAMs in cancer metastasis.
Copyright © 2014 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  CAMs; Galectin-3; Metastasis; Muc1

Mesh:

Substances:

Year:  2014        PMID: 25661355     DOI: 10.1016/j.biopha.2014.11.024

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  27 in total

1.  Identification of NCCRP1 as an epigenetically regulated tumor suppressor and biomarker for malignant phenotypes of squamous cell carcinoma of the esophagus.

Authors:  Takashi Miwa; Mitsuro Kanda; Masahiko Koike; Naoki Iwata; Haruyoshi Tanaka; Shinichi Umeda; Chie Tanaka; Daisuke Kobayashi; Masamichi Hayashi; Suguru Yamada; Tsutomu Fujii; Michitaka Fujiwara; Yasuhiro Kodera
Journal:  Oncol Lett       Date:  2017-08-14       Impact factor: 2.967

2.  Genetic analysis of radiation-specific biomarkers in sinonasal squamous cell carcinomas.

Authors:  Li Yan; Cheng Zhan; Shengzi Wang; Shuyi Wang; Luo Guo
Journal:  Tumour Biol       Date:  2016-05-10

3.  MicroRNA-9 is a ponderable index for the prognosis of human hepatocellular carcinoma.

Authors:  Jingchang Sun; Kunpeng Fang; Hang Shen; Yeben Qian
Journal:  Int J Clin Exp Med       Date:  2015-10-15

4.  Galectin-3 may serve as a potential marker for diagnosis and prognosis in papillary thyroid carcinoma: a meta-analysis.

Authors:  Weiwei Tang; Congwei Huang; Chongyin Tang; Jin Xu; Hanjin Wang
Journal:  Onco Targets Ther       Date:  2016-01-22       Impact factor: 4.147

Review 5.  Galectins and Carcinogenesis: Their Role in Head and Neck Carcinomas and Thyroid Carcinomas.

Authors:  Nadège Kindt; Fabrice Journe; Ghanem E Ghanem; Sven Saussez
Journal:  Int J Mol Sci       Date:  2017-12-18       Impact factor: 5.923

6.  A genome-wide CRISPR screen reconciles the role of N-linked glycosylation in galectin-3 transport to the cell surface.

Authors:  Sarah E Stewart; Sam A Menzies; Stephanie J Popa; Natalia Savinykh; Anna Petrunkina Harrison; Paul J Lehner; Kevin Moreau
Journal:  J Cell Sci       Date:  2017-08-03       Impact factor: 5.285

7.  The expression of Galectin-3 in endometrial cancer: a systematic review of the literature.

Authors:  Ioannis Boutas; Adamantia Kontogeorgi; Constantine Dimitrakakis; Sophia N Kalantaridou
Journal:  Mol Biol Rep       Date:  2021-07-09       Impact factor: 2.316

Review 8.  The Interplay of Reactive Oxygen Species, Hypoxia, Inflammation, and Sirtuins in Cancer Initiation and Progression.

Authors:  Marco Tafani; Luigi Sansone; Federica Limana; Tania Arcangeli; Elena De Santis; Milena Polese; Massimo Fini; Matteo A Russo
Journal:  Oxid Med Cell Longev       Date:  2015-12-20       Impact factor: 6.543

9.  Identification of Key Genes and Pathways in Tongue Squamous Cell Carcinoma Using Bioinformatics Analysis.

Authors:  Huayong Zhang; Jianmin Liu; Xiaoyan Fu; Ankui Yang
Journal:  Med Sci Monit       Date:  2017-12-14

10.  Neuroligin 4X overexpression in human breast cancer is associated with poor relapse-free survival.

Authors:  Henry J Henderson; Balasubramanyam Karanam; Rajeev Samant; Komal Vig; Shree R Singh; Clayton Yates; Deepa Bedi
Journal:  PLoS One       Date:  2017-12-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.